Apricus Wealth’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5K | Sell |
47,462
-1,500
| -3% | -$900 | 0.02% | 114 |
|
|
2025
Q1 | $13.2K | Hold |
48,962
| – | – | 0.01% | 117 |
|
|
2024
Q4 | $25.5K | Sell |
48,962
-30,000
| -38% | -$15.6K | 0.02% | 101 |
|
|
2024
Q3 | $256K | Buy |
78,962
+100
| +0.1% | +$324 | 0.17% | 85 |
|
|
2024
Q2 | $237K | Hold |
78,862
| – | – | 0.17% | 82 |
|
|
2024
Q1 | $367K | Hold |
78,862
| – | – | 0.26% | 75 |
|
|
2023
Q4 | $326K | Buy |
78,862
+1,500
| +2% | +$6.21K | 0.25% | 71 |
|
|
2023
Q3 | $240K | Buy |
77,362
+33
| +0% | +$102 | 0.21% | 74 |
|
|
2023
Q2 | $220K | Hold |
77,329
| – | – | 0.19% | 76 |
|
|
2023
Q1 | $175K | Hold |
77,329
| – | – | 0.16% | 79 |
|
|
2022
Q4 | $270K | Sell |
77,329
-30,000
| -28% | -$105K | 0.25% | 71 |
|
|
2022
Q3 | $3.97M | Buy |
107,329
+73,995
| +222% | +$2.74M | 3.95% | 2 |
|
|
2022
Q2 | $633K | Sell |
33,334
-600
| -2% | -$11.4K | 0.58% | 46 |
|
|
2022
Q1 | $885K | Hold |
33,934
| – | – | 0.72% | 43 |
|
|
2021
Q4 | $765K | Buy |
+33,934
| New | +$765K | 0.68% | 52 |
|